Dry eye disease symptoms and quality of life in perimenopausal and postmenopausal women

References

• Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf 2017;15:276–83
   PubMed Web of Science ®Google Scholar
• Lemp MA. Advances in understanding and managing dry eye disease. Am J Ophthalmol 2008;146:350–6
   PubMed Web of Science ®Google Scholar
• Friedman NJ. Impact of dry eye disease and treatment on quality of life. Curr Opin Ophthalmol 2010;21:310–16
   PubMed Web of Science ®Google Scholar
• Schaumberg DA, Uchino M, Christen WG, Semba RD, Buring JE, Li JZ. Patient reported differences in dry eye disease between men and women: impact, management and patient satisfaction. PLoS One 2013;8:e76121
   PubMed Web of Science ®Google Scholar
• Brown MM, Brown GC. Utility assessment and dry eye disease. Ophthalmology 2004;111:852–3
   PubMed Web of Science ®Google Scholar
• Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II Epidemiology Report. Ocul Surf 2017;15:334–65
   PubMed Web of Science ®Google Scholar
• Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003;136:318–26
   PubMed Web of Science ®Google Scholar
• Moss SE, Klein R, Klein BE. Long-term incidence of dry eye in an older population. Optom Vis Sci 2008;85:668–74
   PubMed Web of Science ®Google Scholar
• Viso E, Rodriguez-Ares MT, Gude F. Prevalence of and associated factors for dry eye in a Spanish adult population (the Salnes Eye Study). Ophthalmic Epidemiol 2009;16:15–21
   PubMed Web of Science ®Google Scholar
• Farrand KF, Fridman M, Stillman IÖ, Sachaumberg DA. Prevalence of diagnosed dry eye disease in the United States among adults aged 18 years and older. Am J Ophthalmol 2017;182:90–8
   PubMed Web of Science ®Google Scholar
• Matossian C, McDonald M, Donaldson KE, Nichols KK, MacIver S, Gupta PK. Dry eye disease: consideration for women’s health. J Womens Health (Larchmt) 2019;28:502–514
   PubMed Web of Science ®Google Scholar
• Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II Diagnostic Methodology report. Ocul Surf 2017;15:539–74
   PubMed Web of Science ®Google Scholar
• Walt JG, Rowe MM, Stern KL. Evaluating the functional impact of dry eye: the ocular surface disease index. Drug Inf J 1997;31:1436
   Google Scholar
• Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the ocular surface disease index. Arch Ophthalmol 2000;118:615–21
   PubMed Web of Science ®Google Scholar
• Mizuno Y, Yamada M, Miyake Y, and the Dry Eye Survey Group of the National Hospital Organization of Japan. Association between clinical diagnostic tests and health-related quality of life surveys in patients with dry eye syndrome. Jpn J Ophthalmol 2010;54:259–65
   PubMed Web of Science ®Google Scholar
• Garcia-Alfaro P, Bergamaschi L, Marcos C, Garcia S, Rodriguez I. Prevalence of ocular surface disease symptoms in peri- and postmenopausal women. Menopause 2020;27:993–8
   PubMed Web of Science ®Google Scholar
• Harlow SD, Gass M, Hall JE, et al. Executive summary of the stages of reproductive aging workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause 2012;19:387–95
   PubMed Web of Science ®Google Scholar
• Beltran F, R, Betancourt N, Martinez J, et al. Transcultural validation of ocular surface disease index (OSDI) questionnaire for Mexican population. Invest Ophthalmol Vis Sci 2013;54:6050
   Web of Science ®Google Scholar
• Baudouin C, Messmer EM, Aragona P, et al. Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of Meibomian gland dysfunction. Br J Ophthalmol 2016;100:300–6
   PubMed Web of Science ®Google Scholar
• Sullivan DA, Rocha EM, Aragona P, et al. TFOS DEWS II sex, gender, and hormones report. Ocul Surf 2017;15:284–333
   PubMed Web of Science ®Google Scholar
• Uchino M, Nishiwaki Y, Michikawa T, et al. Prevalence and risk factors of dry eye disease in Japan: Koumi study. Ophthalmology 2011;118:2361–7
   PubMed Web of Science ®Google Scholar
• Malet F, Le Goff M, Colin J, et al. Dry eye disease in French elderly subjects: the Alienor Study. Acta Ophthalmol 2014;92:429–36
   PubMed Web of Science ®Google Scholar
• Vehof J, Kozareva D, Hysi PG, Hammond CJ. Prevalence and risk factors of dry eye disease in a British female cohort. Br J Ophthalmol 2014;98:1712–17
   PubMed Web of Science ®Google Scholar
• Özcura F, Aydin S, Helvaci MR. Ocular surface disease index for the diagnosis of dry eye syndrome. Ocul Immunol Inflamm 2007;15:389–93
   PubMed Web of Science ®Google Scholar
• Simpson TL, Situ O, Jones LW, et al. Dry eye symptoms assessed by four questionnaires. Optom Vis Sci 2008;85:692–9
   PubMed Web of Science ®Google Scholar
• Miljanovic B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol 2007;143:409–15
   PubMed Web of Science ®Google Scholar
• Tong L, Waduthantri S, Wong TY, et al. Impact of symptomatic dry eye on vision-related daily activities: the Singapore Malay Eye Study. Eye (Lond) 2010;24:1486–91
   PubMed Web of Science ®Google Scholar
• Deschamps N, Ricaud X, Rabut G, Labbé A, Baudouin C, Denoyer A. The impact of dry eye disease on visual performance while driving. Am J Ophthalmol 2013;156:184–9
   PubMed Web of Science ®Google Scholar
• Uchino M, Yokoi N, Uchino Y, et al. Prevalence of dry eye disease and its risk factors in visual display terminal users: the Osaka study. Am J Ophthalmol 2013;156:759–66
   PubMed Web of Science ®Google Scholar
• Kawashima M, Yamatsuji M, Yokoi N, et al. Screening of dry eye disease in visual display terminal workers during occupational health examinations: the Moriguchi study. J Occup Health 2015;57:253–8
   PubMed Web of Science ®Google Scholar
• Courtin R, Pereira B, Naughton G, et al. Prevalence of dry eye disease in visual display terminal workers: a systematic review and meta-analysis. BMJ Open 2016;6:e009675
   PubMed Web of Science ®Google Scholar
• Iyer JV, Lee SY, Tong L. The dry eye disease activity log study. Sci World J 2012;2012:1–7
   Google Scholar
• Harris RA, Nease RF. Jr. The importance of patient preferences for comorbidities in cost-effectiveness analyses. J Health Econ 1997;16:113–19
   PubMed Web of Science ®Google Scholar
• Schiffman RM, Walt JG, Jacobsen G, et al. Utility assessment among patients with dry eye disease. Ophthalmology 2003;110:1412–19
   PubMed Web of Science ®Google Scholar
• Buchholz P, Steeds CS, Stern LS, et al. Utility asseement to measure the impact of dry eye disease. Ocul Surf 2006;4:155–61
   PubMed Web of Science ®Google Scholar
• Uchino M, Uchino Y, Dogru M, et al. Dry eye disease and work productivity loss in visual display users: The Osaka study. Am J Ophthalmol 2014;157:294–300
   PubMed Web of Science ®Google Scholar
• McDonald M, Patel DA, Keith MS, Snedecor SJ. Economic and humanistic burden of dry eye disease in Europe, North America, and Asia: a systematic literature review. Ocul Surf 2016;14:144–67
   PubMed Web of Science ®Google Scholar
• Uchino M, Schaumberg DA. Dry eye disease: impact on quality of life and vision. Curr Ophthalmol Rep 2013;1:51–7
   PubMedGoogle Scholar
• Jones L, Downie LE, Korb D, et al. TFOS DEWS II management and therapy report. Ocul Surf 2017;15:575–628
   PubMed Web of Science ®Google Scholar